Replies to post #38802 on Ariad Pharmaceuticals Inc fka ARIA

[DewDiligence]

What would Ariad gain by not charging? Would it be an effort to gain goodwill or is there something else.

Some people have opined that ARIA doesn’t want to reveal what the production cost is, which they would have to do implicitly if they charged patients in the treatment IND. I don’t buy this argument, however.

More likely, IMO, is that ARIA thinks the goodwill from free treatment can be leveraged somehow to get a better outcome from the FDA. In reality, the FDA probably isn't influenced by any of this, however.